Bio-Rad Laboratories (BIO-B) Total Debt (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Total Debt data on file, last reported at $802.9 million in Q1 2026.

• Total Debt for Q1 2026 came in at $802.9 million, down 33.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $802.9 million (down 33.13% YoY), and the FY2025 annual result was $1.2 billion, changed 0.11% from the prior year.
• Total Debt retreated to $802.9 million in Q1 2026 per BIO-B's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Total Debt peaked at $1.2 billion in Q4 2025 and troughed at $802.9 million in Q1 2026.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2023 frame the typical range for Total Debt.
• The sharpest annual moves came in 2022 and 2026: Total Debt jumped 11291.63% in 2022, then plunged 33.13% in 2026.
• A 5-year view of Total Debt shows it stood at $1.2 billion in 2022, then rose by 0.12% to $1.2 billion in 2023, then climbed by 0.11% to $1.2 billion in 2024, then climbed by 0.11% to $1.2 billion in 2025, then tumbled by 33.19% to $802.9 million in 2026.
• Business Quant data shows BIO-B's Total Debt at $802.9 million in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.